Inflammatory Cardiomyopathy Clinical Trials

6 recruiting

Inflammatory Cardiomyopathy Trials at a Glance

6 actively recruiting trials for inflammatory cardiomyopathy are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Milan, Bologna, and Heidelberg. Lead sponsors running inflammatory cardiomyopathy studies include Scientific Institute San Raffaele, Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, and Niguarda Hospital.

Browse inflammatory cardiomyopathy trials by phase

Treatments under study

About Inflammatory Cardiomyopathy Clinical Trials

Looking for clinical trials for Inflammatory Cardiomyopathy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Cardiomyopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Cardiomyopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Heart FailureCardiomyopathiesMyocarditis+2 more
Niguarda Hospital80 enrolled10 locationsNCT06158698
Recruiting

Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort

Myocarditis AcuteInflammatory Cardiomyopathy
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia3,000 enrolled1 locationNCT06898762
Recruiting
Phase 2Phase 3

The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy

MyocarditisInflammatory Cardiomyopathy
Tongji Hospital200 enrolled1 locationNCT05961202
Recruiting

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)

Genetic PredispositionMyocarditisVentricular Arrhythmia+1 more
Scientific Institute San Raffaele20 enrolled1 locationNCT06591260
Recruiting

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

Genetic PredispositionMyocarditisVentricular Arrythmia+1 more
Scientific Institute San Raffaele1,000 enrolled1 locationNCT04521790
Recruiting

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies

AmyloidosisNon-ischemic CardiomyopathyArrhythmogenic Right Ventricular Cardiomyopathy+5 more
University Hospital Heidelberg2,040 enrolled1 locationNCT04265040